COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs.
作者信息
Rodriguez-Morales Alfonso J, Sah Ranjit, Millan-Oñate Jose, Gonzalez Angel, Montenegro-Idrogo Juan J, Scherger Sias, Franco-Paredes Carlos, Henao-Martínez Andrés F
机构信息
Grupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de las Américas, Belmonte, Pereira, Risaralda 660003, Colombia. Associate Editor, Therapeutic Advances in Infectious Disease.
Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal.
出版信息
Ther Adv Infect Dis. 2021 Jun 18;8:20499361211027065. doi: 10.1177/20499361211027065. eCollection 2021 Jan-Dec.
Abstract
摘要
相似文献
1
COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs.新型冠状病毒肺炎相关毛霉菌病：迫切需要重新审视免疫抑制药物的滥用问题。
Ther Adv Infect Dis. 2021 Jun 18;8:20499361211027065. doi: 10.1177/20499361211027065. eCollection 2021 Jan-Dec.
2
Rhinocerebral Mucormycosis and COVID-19 Pneumonia.鼻脑型毛霉菌病与新型冠状病毒肺炎
J Med Cases. 2021 Mar;12(3):85-89. doi: 10.14740/jmc3637. Epub 2021 Jan 19.
3
Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports.当代毛霉病的治疗管理和临床结局：病例报告的系统评价和荟萃分析。
Int J Antimicrob Agents. 2019 May;53(5):589-597. doi: 10.1016/j.ijantimicag.2019.01.002. Epub 2019 Jan 10.
4
Mucor in a Viral Land: A Tale of Two Pathogens.霉菌在病毒之地：两种病原体的故事。
Indian J Ophthalmol. 2021 Feb;69(2):244-252. doi: 10.4103/ijo.IJO_3774_20.
5
Mucormycosis in systemic autoimmune diseases.系统性自身免疫性疾病中的毛霉菌病。
Joint Bone Spine. 2014 Jul;81(4):303-7. doi: 10.1016/j.jbspin.2014.01.002. Epub 2014 Mar 3.
6
COVID-19 Pandemic: A Case for Phytomedicines.COVID-19大流行：植物药的一个实例
Nat Prod Commun. 2020 Aug 14;15(8):1934578X20945086. doi: 10.1177/1934578X20945086. eCollection 2020 Aug.
7
[Case report of mucormycosis in a patient with secondary methimazole-induced agranulocytosis].[继发于甲巯咪唑诱导的粒细胞缺乏症患者的毛霉菌病病例报告]
Gac Med Mex. 2009 May-Jun;145(3):235-8.
8
Sino-orbital mucormycosis in a COVID-19 patient: A case report.一名新冠肺炎患者的鼻窦眼眶毛霉菌病：病例报告
Int J Surg Case Rep. 2021 May;82:105957. doi: 10.1016/j.ijscr.2021.105957. Epub 2021 May 4.
9
Salvage Treatment of Mucormycosis Post-Liver Transplant With Posaconazole During Sirolimus Maintenance Immunosuppression.在西罗莫司维持免疫抑制期间，泊沙康唑对肝移植术后毛霉菌病的挽救治疗
J Pharm Pract. 2017 Apr;30(2):261-265. doi: 10.1177/0897190016628702. Epub 2016 Jul 8.
10
Clinical spectrum of pulmonary mucormycosis.肺毛霉病的临床谱
Chest. 1986 Mar;89(3):435-9. doi: 10.1378/chest.89.3.435.
引用本文的文献
1
Craniofacial Involvement of Mucormycosis: A Single-Center Experience of 57 Cases From Shiraz, Iran.毛霉菌病的颅面部累及：来自伊朗设拉子的57例单中心经验
Can J Infect Dis Med Microbiol. 2025 Jul 30;2025:4780569. doi: 10.1155/cjid/4780569. eCollection 2025.
2
Antimicrobial stewardship principles in the evaluation of empirical carbapenem antibiotics in a private hospital in South Africa.南非一家私立医院中经验性碳青霉烯类抗生素评估中的抗菌药物管理原则
JAC Antimicrob Resist. 2025 Mar 5;7(2):dlaf025. doi: 10.1093/jacamr/dlaf025. eCollection 2025 Apr.
3
Outcome of Total Surgical Debridement of Covid Associated Rhino-Orbito-Cerebral Mucormycosis Based on a New Surgical Staging System: A Cohort Study.基于一种新的手术分期系统的新冠相关鼻眶脑毛霉菌病全手术清创结果：一项队列研究
Indian J Otolaryngol Head Neck Surg. 2024 Feb;76(1):298-308. doi: 10.1007/s12070-023-04151-z. Epub 2023 Aug 29.
4
Clinical, Demographic, and Oral Presentations of COVID-19 Associated Mucormycosis from a Tertiary Care Hospital in India: A Cross-Sectional Study.印度一家三级护理医院中与COVID-19相关的毛霉菌病的临床、人口统计学和口腔表现：一项横断面研究
J Maxillofac Oral Surg. 2023 Dec;22(4):1130-1138. doi: 10.1007/s12663-023-01970-z. Epub 2023 Jul 11.
5
The Fragile Patient: Considerations in the Management of Invasive Mould Infections (IMIs) in India.脆弱患者：印度侵袭性霉菌感染（IMIs）管理中的考量
Cureus. 2023 Apr 24;15(4):e38085. doi: 10.7759/cureus.38085. eCollection 2023 Apr.
6
Effect of nurse-led intervention on knowledge and preventive behavior of diabetic pregnant women regarding COVID-19 associated mucromycosis infection in mid-delta region of Egypt.护士主导的干预措施对埃及三角洲中部地区糖尿病孕妇关于2019冠状病毒病相关毛霉菌病感染的知识及预防行为的影响
BMC Nurs. 2023 May 22;22(1):175. doi: 10.1186/s12912-023-01320-x.
7
Quality of life in patients treated for COVID-19-associated mucormycosis at a tertiary care hospital.在一家三级护理医院接受新冠病毒相关毛霉菌病治疗的患者的生活质量。
Osong Public Health Res Perspect. 2023 Apr;14(2):119-128. doi: 10.24171/j.phrp.2022.0307. Epub 2023 Apr 18.
8
Diagnosis of type 2 diabetes in a patient with acute sinusitis and COVID-19 in Colombia.哥伦比亚一名患有急性鼻窦炎和新冠肺炎患者的2型糖尿病诊断
IDCases. 2023;31:e01664. doi: 10.1016/j.idcr.2022.e01664. Epub 2023 Jan 2.
9
A case control investigation of COVID-19 associated mucormycosis in India.印度 COVID-19 相关毛霉菌病的病例对照研究。
BMC Infect Dis. 2022 Nov 16;22(1):856. doi: 10.1186/s12879-022-07844-y.
10
Pathogenesis and Pathology of COVID-Associated Mucormycosis: What Is New and Why.新型冠状病毒相关毛霉菌病的发病机制与病理学：新进展及原因
Curr Fungal Infect Rep. 2022;16(4):206-220. doi: 10.1007/s12281-022-00443-z. Epub 2022 Sep 29.
本文引用的文献
1
Mucormycosis-A serious threat in the COVID-19 pandemic?毛霉病——新冠疫情中的严重威胁？
J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.05.015. Epub 2021 May 21.
2
Mucormycosis.毛霉菌病。
Infect Dis Clin North Am. 2021 Jun;35(2):435-452. doi: 10.1016/j.idc.2021.03.009.
3
Rise of the phoenix: Mucormycosis in COVID-19 times.凤凰涅槃：新冠时期的毛霉菌病。
Indian J Ophthalmol. 2021 Jun;69(6):1563-1568. doi: 10.4103/ijo.IJO_310_21.
4
Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of COVID-19.毛霉代码：2019冠状病毒病背景下鼻眶脑型毛霉病的诊断、分期和管理指南
Indian J Ophthalmol. 2021 Jun;69(6):1361-1365. doi: 10.4103/ijo.IJO_1165_21.
5
The use of posaconazole delayed-release tablets in the successful treatment of suspected mucormycosis in a bottlenose dolphin () calf.泊沙康唑缓释片成功用于治疗一头宽吻海豚幼崽疑似毛霉菌病。
Med Mycol Case Rep. 2021 Apr 26;32:77-80. doi: 10.1016/j.mmcr.2021.04.003. eCollection 2021 Jun.
6
Rhinocerebral Mucormycosis and COVID-19 Pneumonia.鼻脑型毛霉菌病与新型冠状病毒肺炎
J Med Cases. 2021 Mar;12(3):85-89. doi: 10.14740/jmc3637. Epub 2021 Jan 19.
7
Sino-orbital mucormycosis in a COVID-19 patient: A case report.一名新冠肺炎患者的鼻窦眼眶毛霉菌病：病例报告
Int J Surg Case Rep. 2021 May;82:105957. doi: 10.1016/j.ijscr.2021.105957. Epub 2021 May 4.
8
Pulmonary Mucormycosis.肺毛霉病
N Engl J Med. 2021 May 6;384(18):e69. doi: 10.1056/NEJMicm2030205. Epub 2021 May 1.
9
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis.当未控制的糖尿病与重症 COVID-19 相遇：毛霉菌病的完美风暴。
J Fungi (Basel). 2021 Apr 15;7(4):298. doi: 10.3390/jof7040298.
10
COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?COVID-19 诱发易感患者发生毛霉菌病：发展中国家的一种新现象？
BMJ Case Rep. 2021 Apr 27;14(4):e241663. doi: 10.1136/bcr-2021-241663.
Zotero 插件